
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Signant Health has been selected to provide electronic informed consent for a significant neuroscience study by the Shanghai Mental Health Center. This investigator-led Schizophrenia trial will enroll hundreds of patienta and implement Signant’s TrialConsent solution in China.
To learn more, click






